{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-125937","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2024-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.470767+00:00","generated_at":"2026-05-29T07:12:01.355756+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ironwood CFO Sravan Emany resigns effective Dec 18; CEO McCourt interim PFO","bullets":["Sravan Emany resigns as SVP, COO, and CFO effective Dec 18, 2024.","Resignation not due to any disagreement on financial reporting matters.","CEO Thomas McCourt will serve as interim principal financial officer.","Company will search for a new CFO; interim arrangement in place."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-125937","json":"https://secwatch.observer/filing/0001104659-24-125937.json","markdown":"https://secwatch.observer/filing/0001104659-24-125937.md","text":"https://secwatch.observer/filing/0001104659-24-125937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465924125937/0001104659-24-125937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465924125937/tm2430282d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T07:12:01.355756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}